Personalized cancer medicine

Personalized cancer medicine include studying a person's genetic makeup and tumor growth to prevent, diagnose and/or treat disease. Here is the latest research on personalized cancer medicine.

September 17, 2021

TIMP1 expression underlies sex disparity in liver metastasis and survival in pancreatic cancer.

The Journal of Experimental Medicine
Chris D HermannAchim Krüger
September 17, 2021

Rational design and development of HDAC inhibitors for breast cancer treatment.

Current Pharmaceutical Design
Deepansh ModyVibha Gupta
September 17, 2021
Open Access

Non-Small Cell Lung Cancer: Challenge and Improvement of Immune Drug Resistance.

Frontiers in Oncology
Fanming KongYingjie Jia
September 17, 2021

[Identification and inner relation between gastrointestinal stromal tumor and intra-abdominal desmoid tumor].

Zhonghua wei chang wai ke za zhi = Chinese journal of gastrointestinal surgery
B NiH Cao
September 16, 2021

Applying Machine Learning to Stem Cell Culture and Differentiation.

Current Protocols
Mishal AshrafZachary Laksman
September 16, 2021

How much can deep learning improve prediction of the responses to drugs in cancer cell lines?

Briefings in Bioinformatics
Yurui Chen, Louxin Zhang
September 16, 2021

Adjuvant therapy in non-small cell lung cancer: is targeted therapy joining the standard of care?

Expert Review of Anticancer Therapy
Carolina GabayChristian Rolfo Cervetto
September 16, 2021

Status of N-of-1 Trials in Chronic Pain Management: A Narrative Review.

Pain and Therapy
Wanying HeFengxian Li
September 16, 2021
Open Access

Influential Usage of Big Data and Artificial Intelligence in Healthcare.

Computational and Mathematical Methods in Medicine
Yan Cheng YangShah Nazir
September 16, 2021

Clinical impact of detecting low-frequency variants in cell-free DNA on treatment of castration-resistant prostate cancer.

Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
Kei MizunoShusuke Akamatsu
September 13, 2021

ASGARD: A Single-cell Guided pipeline to Aid Repurposing of Drugs

Bing He, Lana X. Garmire
September 16, 2021

An Overview of the Genomic Characterization of Hepatocellular Carcinoma.

Journal of Hepatocellular Carcinoma
Sun Young Yim, Ju-Seog Lee
September 16, 2021

Mapping the landscape of synthetic lethal interactions in liver cancer.

Chen YangDayong Zhang
September 15, 2021
Open Access

Assessment of CAR-T mediated and targeted cytotoxicity in 3D microfluidic TBNC co-culture models for combination therapy

BioRxiv : the Preprint Server for Biology
K. A. F. PatersonMichele Zagnoni
September 15, 2021

m6A Pathway Regulators Are Frequently Mutated in Breast Invasive Carcinoma and May Play an Important Role in Disease Pathogenesis.

Omics : a Journal of Integrative Biology
Turan DemircanSıddıka Akgül

Sign up to follow this feed and discover related papers.

Related Feeds

Angiogenesis Inhibitors to Treat Cancer

Cancer treatments including angiogenesis inhibitors prevent tumor cells from receiving nutrients and oxygen. Here is the latest research on angiogenesis inhibitors for the treatment of cancer.

Biosensors for Cancer Detection

Biosensors are devices that are designed to detect a specific biological analyte by essentially converting a biological entity (ie, protein, DNA, RNA) into an electrical signal that can be detected and analyzed. The use of biosensors in cancer detection and monitoring holds vast potential. Biosensors can be designed to detect emerging cancer biomarkers and to determine drug effectiveness at various target sites. Biosensor technology has the potential to provide fast and accurate detection, reliable imaging of cancer cells, and monitoring of angiogenesis and cancer metastasis, and the ability to determine the effectiveness of anticancer chemotherapy agents.

Breast Cancer: Chemo-Resistance

Some cancers are difficult to treat and aggressive including the "triple-negative" breast cancer. This type of cancer is chemoresistant even before chemotherapy begins. Here are the latest discoveries chemo-resistance in breast cancer.

CAR-T cells

Chimeric antigen receptor (CAR) T cells are cells that are genetically engineered to recognize and target specific proteins. The ability of these cells to recognize cancer antigens and eliminate tumor cells have transformed cancer immunotherapy approaches. Here is the latest research on CAR-T cells.

Cancer -Omics

A variety of different high-throughput technologies can be used to identify the complete catalog of changes that characterize the molecular profile of cohorts of tumor samples. Discover the latest insights gained from cancer 'omics' in this feed.

Cancer Cell Invasion: Nanomedicine

Nanomedicine is a promising alternative for cancer detection and therapy that utilizes nanoparticles, such as liposomes. Nanoparticles can potentially target cancer cell invasion and metastasis. Discover the latest research on Cancer Cell Invasion: Nanomedicine here.

Cancer Disparities

Cancer disparities refers to differences in cancer outcomes (e.g., number of cancer cases, related health complications) across population groups.

Cancer Immunotherapy

Cancer immunotherapy is an important field of research that is looking at controlling cancer and tumor growth by activating the individuals own immune system. Recent studies have utilized chimeric antigen receptor t-cell therapy, immune checkpoint inhibitors and neoantigen vaccines. Discover the latest research on cancer immunotherapy here.

Cancer Incidence & Mortality

Cancer has emerged as a global concern due to its increase in incidence and mortality. Efforts are underway to evaluate and develop action plans to reduce the global burden of cancer. Currently, lung cancer, breast cancer and prostate cancer are the leading causes of cancer mortality. Here is the latest research on cancer incidence and mortality.

Cancer Metabolic Reprogramming

Cancer metabolic reprogramming is important for the rapid growth and proliferation of cancer cells. Cancer cells have the ability to change their metabolic demands depending on their environment, regulated by the activation of oncogenes or loss of tumor suppressor genes. Here is the latest research on cancer metabolic reprogramming.

© 2021 Meta ULC. All rights reserved